We are live on ! Find out more
GCA

Greenwood Capital Associates Portfolio holdings

AUM $1.02B
1-Year Est. Return 28.26%
This Fund
S&P 500
This Quarter Est. Return
-0.09%
1 Year Est. Return
+28.26%
3 Year Est. Return
+81.29%
5 Year Est. Return
+95.78%
10 Year Est. Return
+421.94%
AUM
$908M
AUM Growth
-$13.3M
Cap. Flow
+$7.68M
Cap. Flow %
0.85%
Top 10 Hldgs %
25.34%
Holding
311
New
55
Increased
103
Reduced
113
Closed
25

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$5.82M
2
P
Everpure Inc
P
+$5.56M
3
DOW icon
Dow Inc
DOW
+$5M
4
ADBE icon
Adobe
ADBE
+$4.81M
5
TMUS icon
T-Mobile US
TMUS
+$4.81M

Top Sells

Rank Stock Value
1
ASML icon
ASML
ASML
+$7.88M
2
APH icon
Amphenol
APH
+$6.34M
3
ALB icon
Albemarle
ALB
+$6.02M
4
SYK icon
Stryker
SYK
+$5.98M
5
EOG icon
EOG Resources
EOG
+$5.15M

Sector Composition

Rank Sector Weight
1 Technology 17.64%
2 Healthcare 8.62%
3 Financials 8.08%
4 Communication Services 6.27%
5 Consumer Discretionary 5.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLF icon
276
State Street Financial Select Sector SPDR ETF
XLF
$59.1B
$254K 0.03%
5,143
-4,649
-47% -$242K
EMBX
277
VanEck Emerging Markets Bond ETF
EMBX
$263M
$252K 0.03%
+5,038
New +$258K
XLK icon
278
State Street Technology Select Sector SPDR ETF
XLK
$124B
$245K 0.03%
1,842
-556
-23% -$78.3K
SFM icon
279
Sprouts Farmers Market
SFM
$8.03B
$245K 0.03%
+3,171
New +$237K
IVW icon
280
iShares S&P 500 Growth ETF
IVW
$77.3B
$244K 0.03%
2,160
VMC icon
281
Vulcan Materials
VMC
$36.3B
$241K 0.03%
885
T icon
282
AT&T
T
$166B
$235K 0.03%
+8,119
New +$217K
XLI icon
283
State Street Industrial Select Sector SPDR ETF
XLI
$34.7B
$218K 0.02%
1,346
-302
-18% -$50.7K
KRYS icon
284
Krystal Biotech
KRYS
$9.85B
$215K 0.02%
+834
New +$222K
EWJ icon
285
iShares MSCI Japan ETF
EWJ
$23.1B
$211K 0.02%
2,495
-1,197
-32% -$104K
HCA icon
286
HCA Healthcare
HCA
$89.8B
$202K 0.02%
+427
New +$215K
ALB icon
287
Albemarle
ALB
$15.1B
-42,530
Closed -$6.02M
APH icon
288
Amphenol
APH
$210B
-46,910
Closed -$6.34M
APO icon
289
Apollo Global Management
APO
$81.9B
-27,333
Closed -$3.96M
APYX icon
290
Apyx Medical
APYX
$126M
-22,789
Closed -$79.8K
ASML icon
291
ASML
ASML
$695B
-7,367
Closed -$7.88M
BAX icon
292
Baxter International
BAX
$13.9B
-16,186
Closed -$309K
CASY icon
293
Casey's General Stores
CASY
$31B
-1,311
Closed -$725K
CB icon
294
Chubb
CB
$132B
-13,666
Closed -$4.27M
CMA
295
DELISTED
Comerica
CMA
-16,211
Closed -$1.41M
EG icon
296
Everest Group
EG
$13.9B
-1,331
Closed -$452K
EOG icon
297
EOG Resources
EOG
$75.1B
-49,046
Closed -$5.15M
FITB
298
Fifth Third Bancorp
FITB
$52.6B
-44,539
Closed -$2.08M
HBIO icon
299
Harvard Bioscience
HBIO
$28.1M
-2,775
Closed -$18.6K
HPQ icon
300
HP
HPQ
$26.8B
-33,608
Closed -$749K

Similar funds

Greenwood Capital Associates's Q1 2026 Portfolio in Review

As of Q1 2026, Greenwood Capital Associates held 311 positions worth $908M, down 1.4% from $921M the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Greenwood Capital Associates's Q1 2026 filing shows 55 new, 103 increased, 113 reduced and 25 closed positions. Its largest new stake was Everpure Inc: 82,029 shares worth $4.84M. The largest sale was ASML, an estimated $7.88M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 19% a quarter earlier, followed by Healthcare and Financials.

  • Greenwood Capital Associates's largest Q1 2026 buy was Everpure Inc: 82,029 shares worth $4.84M.
  • Greenwood Capital Associates added most to Amgen in Q1 2026, an estimated $5.82M increase.
  • Greenwood Capital Associates's biggest Q1 2026 reduction was iShares MSCI China ETF, cutting an estimated $4.71M.
  • Greenwood Capital Associates fully exited ASML in Q1 2026, selling an estimated $7.88M.
  • Greenwood Capital Associates's ten largest holdings make up 25% of its $908M portfolio in Q1 2026.
  • Greenwood Capital Associates opened 55 new positions and closed 25 in Q1 2026.
  • Greenwood Capital Associates's portfolio value fell 1.4% quarter-over-quarter to $908M.

Based on Greenwood Capital Associates's 13F filing for Q1 2026, filed 29 Apr 2026.